Literature DB >> 3942874

Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.

R Cortés, J M Palacios.   

Abstract

The binding characteristics of N[3H]methylscopolamine ([3H]NMS) to slide-mounted tissue sections were studied using quantitative autoradiography. Binding of [3H]NMS was saturable, reversible and of high affinity (Kd = 0.26 nM). The inhibition of [3H]NMS binding produced by several muscarinic agonists and antagonists was analyzed in 29 discrete brain regions by constructing complete displacement curves. Comparison of IC50 values obtained both biochemically and by autoradiography demonstrated a very close agreement, supporting the validity of the autoradiographic approach. The competition curves for the agonists carbachol, oxotremorine and 2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion-h ydrobromide (RS 86) fitted to a two-site model, with comparable affinity values from region to region, although different proportions of high- and low-affinity sites were seen in the different areas studied. The distribution of high- and low-affinity sites was similar for the three agonists. Atropine showed monophasic curves presenting similar affinities in all regions studied. In contrast, pirenzepine differentiated between high- and low-affinity sites which showed a distribution opposite to that observed for the agonists. Gallamine, a ligand for a putative regulatory site in the muscarinic receptor, inhibited [3H]NMS binding in a biphasic manner. The calculated IC50 values for the gallamine high- and low-affinity sites did not vary from region to region and the distribution of these sites correlated well with that observed for the agonists. High-affinity pirenzepine sites (also called M1 sites) were localized mainly in forebrain areas, such as striatum, hippocampus and cortex, and their regional distribution correlated with that of the low-affinity sites for the agonists and gallamine. On the other hand, low-affinity sites for pirenzepine (named M2 sites) were mainly found in the brainstem and parts of the thalamus. A good correlation was found between pirenzepine low-affinity sites and agonist and gallamine high-affinity sites. The significance of these findings is discussed in relation to the known and possible effects of selective M1 and M2 centrally acting agents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942874     DOI: 10.1016/0006-8993(86)90448-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  32 in total

1.  Responses of presumed cholinergic mesopontine tegmental neurons to carbachol microinjections in freely moving cats.

Authors:  M el Mansari; K Sakai; M Jouvet
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

2.  Neuronal localization of m1 muscarinic receptor immunoreactivity in the rat basolateral amygdala.

Authors:  Alexander Joseph McDonald; Franco Mascagni
Journal:  Brain Struct Funct       Date:  2010-05-26       Impact factor: 3.270

Review 3.  Organization and physiology of the substantia nigra.

Authors:  H Condé
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

4.  Muscarine reduces inwardly rectifying potassium conductance in rat nucleus accumbens neurones.

Authors:  N Uchimura; R A North
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

5.  Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice.

Authors:  Kelly A Carrigan; Linda A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

6.  Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

Authors:  D M Weiner; A I Levey; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 7.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

8.  In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.

Authors:  V I Cohen; B R Zeeberg; S F Boulay; V K Sood; M R Rayeq; R A Danesh; D W McPherson; R C Reba
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

9.  Fluorescence changes reveal kinetic steps of muscarinic receptor-mediated modulation of phosphoinositides and Kv7.2/7.3 K+ channels.

Authors:  Jill B Jensen; John S Lyssand; Chris Hague; Bertil Hille
Journal:  J Gen Physiol       Date:  2009-04       Impact factor: 4.086

10.  Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells.

Authors:  Björn H Falkenburger; Jill B Jensen; Bertil Hille
Journal:  J Gen Physiol       Date:  2010-02       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.